WebApr 13, 2024 · Sarepta Therapeutics Inc ( SRPT) is down -6.73%% today. SRPT has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on SRPT! SRPT stock closed at $137.68 and is down -$9.26 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only … WebTotal sales grew 23% year over year, but lagged more bullish estimates of $131 million, according to Zacks Investment Research. Losses were better than expected at $1.42 per share but widened from ...
SRPT Stock Rockets After Biotech Company
WebMar 29, 2024 · 10 best biotech stocks by one-year performance. Below is a list of the 10 best-performing biotech stocks in the New York Stock Exchange Arca Biotechnology … Web1 day ago · Sarepta Therapeutics plummets 20% after FDA contradicts company and requires advisory meeting. Mar. 16, 2024 at 6:16 p.m. ET by Wallace Witkowski. Biotech … Sarepta Therapeutics Inc. analyst estimates, including SRPT earnings per … The latest options coverage on MarketWatch. ‘Cry me a river, right?’: I … PFE Complete Pfizer Inc. stock news by MarketWatch. View real-time stock … Sarepta Therapeutics Inc. advanced stock charts by MarketWatch. View SRPT … how far is zadar from split
Sarepta Therapeutics Inc (SRPT) has fallen 6.73% Thursday In …
WebDec 13, 2024 · In a stunning reversal, the Food and Drug Administration approved Sarepta Therapeutics ' ( SRPT) previously rejected Duchenne muscular dystrophy drug — … WebIn depth view into SRPT (Sarepta Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. ... Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. ... As of April 06, 2024. Fundamentals. Income Statement. Revenue (TTM) 933.01M ... WebApr 13, 2024 · Sarepta Therapeutics Inc ( SRPT) is down -6.73%% today. SRPT has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on … high commission guyana